A randomised, double-blind, placebo-cont
β
M. C. Khan
π
Article
π
1995
π
John Wiley and Sons
π
English
β 433 KB
Fifty-four hospitalised and outpatients with a DSM 111 diagnosis of major depressive disorder and 21-item HPRSD score of 2 18, were randomised to 5 weeks' of treatment with either Org 3770 (n=27; 20-60mg/day) or placebo (n = 27). The treatment with Org 3770 resulted in statistically significant and